No­var­tis backs Gami­da Cell’s $40M raise to fund a loom­ing PhI­II study, mar­ket­ing and man­u­fac­tur­ing prep

Is­rael’s Gami­da Cell now has the cash it needs to ex­e­cute on a late-stage tri­al for its ex­per­i­men­tal cell graft, which it hopes can be …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland